Utah Medical Products Inc

Research Utah Medical Products Inc (UTMD) on Bullrun: valuation model: fairly valued, market cap USD 232.65M, P/E 21.6, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Utah Medical Products Inc as fairly valued; latest market cap is USD 232.65M; P/E is 21.6; dividend yield is 1.7%.

About Utah Medical Products Inc

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices;

Frequently asked questions

Is Utah Medical Products Inc overvalued or undervalued?

Bullrun's valuation model currently marks Utah Medical Products Inc as fairly valued.

What is Utah Medical Products Inc's market cap?

Utah Medical Products Inc's market capitalization is USD 232.65M.

What is Utah Medical Products Inc's P/E ratio?

Utah Medical Products Inc's price-to-earnings (P/E) ratio is 21.6.

Does Utah Medical Products Inc pay a dividend?

Utah Medical Products Inc has a dividend yield of 1.7%.

What does Utah Medical Products Inc do?

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods;